We are monitoring the impact of COVID-19 on APAC Dialyzer Market Get in touch with us for detailed analysis Know More
Pulished Date September, 2021
ID: 12196
Share on
Share on

APAC Dialyzer Market Research Report – Segmented By Type, End-user, & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast | 2021 to 2026

Pulished: September, 2021
ID: 12196
Pages: 100

APAC Dialyzer Market Size (2021 to 2026)

The APAC dialyzer Market was worth USD 759.48 million in 2021 and is estimated to be growing at a CAGR of 8.92%, to reach USD 1,164.11 million by 2026.

A dialyzer is a medical device that replaces kidney function by using an artificial membrane to remove excess water and metabolic wastes from the blood. Dialyzers are primarily used by healthcare professionals for haemodialysis.

The significant increase in the elderly population and the frequent occurrence of kidney disorders, notably end-stage renal disease, are the key reasons driving the growth of the APAC dialyzer market. Higher adoption of haemodialysis to treat highly prevalent end-stage renal disease, as well as a faster pace of infrastructure development, providing a favourable environment for the installation of haemodialysis machines in emerging countries, are expected to drive the dialyzer market in the Asia Pacific.

Increased funding for improved dialysis products and services, rising diabetes and hypertension rates, and a lack of kidneys for transplantation are expected to propel the industry forward. Because of the existence of expanding economies, rising healthcare spending, and a constantly growing population, Asia Pacific is considered an emerging market for dialyzers. Diabetic and hypertensive nephropathy are the primary causes of kidney problems, and the increased prevalence of these diseases has fuelled the market need for Dialyzers.

Dialyzers are primarily used by medical practitioners during haemodialysis procedures. Haemodialysis is a treatment that removes waste from the blood of people who have chronic or acute renal failure. The evacuation of waste aids in the patient's electrolyte balance. It also prevents the build-up of salts and wastes in the blood, which could result in poisoning. Factors such as the rise in independent dialysis centres, increased awareness of dialysis treatment methods, reimbursement modifications, and healthcare insurance regulations will all contribute to the Asia Pacific region's dialysis product and service business growth.

The dialyzer market is expected to increase because of technical advances that lead to better acceptance and possibilities in emerging markets. Dialyzers used for home dialysis are expected to expand at the quickest CAGR during the forecast period, due to the implementation of modern dialysis products with better efficiency, which allows patients to choose home dialysis, increasing the growth of the APAC dialyzer market.

However, The APAC dialyzer market is projected to be restrained by rising dialyzer costs and severe regulatory regulations. Furthermore, the APAC dialyzers market is expected to be hampered by an increase in dialyzer reuse. The market's growth is also hampered by complications and dangers associated with haemodialyses, such as severe anaemia and fluid overload.

This research report on the APAC dialyzer market has been segmented and sub-segmented into the following categories:

By Type

  • High-Flux
  • Low-Flux

By End-User

  • In Center Dialyzer
  • Home Dialyzer

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand, Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

APAC dialyzer market is going to be expanding due to increased awareness among healthcare professionals, rising healthcare expenditures, improved healthcare infrastructure, and increased medical tourism in the Asia Pacific area. In the Asia Pacific, the incidence and prevalence of chronic kidney failure, as well as the demand for renal replacement therapy, is quickly rising. Infections such as bacterial, mycobacterial, and hepatitis B, among others, are increasing in frequency, contributing to market expansion. According to the International Society of Nephrology, a 52 per cent death rate from acute renal injury infections contributes to the dialysis rate in the Asia Pacific region. In 2020, the dialysis market in Japan generated around USD 6,300.9 million in revenue.


Asahi Kasei Corp., B. Braun Melsungen AG, Baxter International Inc., Medtronic Plc, JMS Co.Ltd., Kawasumi Laboratories Inc., Fresenius Medical Care AG and Co. KGaA, Nikkiso Co. Ltd., Nipro Corp. and Toray Industries Inc. are some of the key players operating in the APAC dialyzer market profiled in this report.

1. Introduction                                   

            1.1 Market Definition            

            1.2 Scope of the report                     

            1.3 Study Assumptions                      

            1.4 Base Currency, Base Year and Forecast Periods             

2. Research Methodology                             

            2.1 Analysis Design                

            2.2 Research Phases              

                        2.2.1 Secondary Research     

                        2.2.2 Primary Research          

                        2.2.3 Data Modelling 

                        2.2.4 Expert Validation          

            2.3 Study Timeline                 

3. Report Overview                            

            3.1 Executive Summary                     

            3.2 Key Inferences                 

4. Market Dynamics                           

            4.1 Impact Analysis                

                        4.1.1 Drivers  

                        4.1.2 Restraints          

                        4.1.3 Opportunities   

            4.2 Regulatory Environment              

            4.3 Technology Timeline & Recent Trends                

5. Competitor Benchmarking Analysis                                  

            5.1 Key Player Benchmarking            

                        5.1.1 Market share analysis   

                        5.1.2 Products/Service          

                        5.1.3 Regional Presence        

            5.2 Mergers & Acquisition Landscape                       

            5.3 Joint Ventures & Collaborations              

6. Market Segmentation                                

            6.1  DIALYZER MARKET, By Type                   

                        6.1.1 High-Flux           

                        6.1.2 Low-Flux

                        6.1.3 Market Size Estimations & Forecasts (2021-2026)      

                        6.1.4 Y-o-Y Growth Rate Analysis      

                        6.1.5 Market Attractiveness Index    

            6.2  DIALYZER MARKET, By End User             

                        6.2.1 In Centre Dialyzer         

                        6.2.2 Home Dialyzer  

                        6.2.3 Market Size Estimations & Forecasts (2021-2026)      

                        6.2.4 Y-o-Y Growth Rate Analysis      

                        6.2.5 Market Attractiveness Index    

7. Geographical Landscape                            

            7.1 Asia Pacific                       

                        7.1.1 By Country        




                           South Korea

                           South East Asia

                           Australia & NZ

                           Rest of Asia-Pacific

                        7.1.2 By Type 

                        7.1.3 By End User      

8. Key Player Analysis                        

            8.1 Asahi Kasei Corp.             

                        8.1.1 Business Description    

                        8.1.2 Products/Service          

                        8.1.3 Financials          

                        8.1.4 SWOT Analysis  

                        8.1.5 Recent Developments  

                        8.1.6 Analyst Overview          

            8.2 B. Braun Melsungen AG               

            8.3 Baxter International Inc.              

            8.4 Medtronic Plc                  

            8.5  JMS Co.Ltd.                     

            8.6 Kawasumi Laboratories Inc.                    

            8.7 Fresenius Medical Care AG and Co.                     

            8.8 KGaA                    

            8.9 Nikkiso Co. Ltd.                

            8.10 Nipro Corp.                    

            8.11  Toray Industries Inc.                 

9. Market Outlook & Investment Opportunities                               

10. Appendix                          

            List of Tables              

            List of Figures  

  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and also identify the areas that are still untapped. 

  • The segment-level analysis in terms of type, end-user, and region along with market size forecasts and estimations to detect key areas of industry growth in detail.

  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.

  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.

  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development.

  • A comprehensive list of key market players along with their product portfolio, current strategic interests, essential financial information, legal issues, SWOT analysis, and analyst overview to study and sustain the market environment.

  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies, and recent developments in the market by the major companies

  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions.

  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations with a strong financial foothold in the market.

  1. Asia Pacific High-Flux Market By Region, From 2021 to 2026 ( USD Billion )

  2. Asia Pacific Low-Flux Market By Region, From 2021 to 2026 ( USD Billion )

  3. Asia Pacific Dialyzer Market  By End User, From 2021 to 2026 ( USD Billion )

  4. Asia Pacific In Center Dialyzer Market By Region, From 2021 to 2026 ( USD Billion )

  5. Asia Pacific Home Dialyzer Market By Region, From 2021 to 2026 ( USD Billion )

  6. Japan Dialyzer Market  By Type, From 2021 to 2026 ( USD Billion )

  7. Japan Dialyzer Market  By End User, From 2021 to 2026 ( USD Billion )

  8. China Dialyzer Market  By Type, From 2021 to 2026 ( USD Billion )

  9. China Dialyzer Market  By End User, From 2021 to 2026 ( USD Billion )

  10. India Dialyzer Market  By Type, From 2021 to 2026 ( USD Billion )

  11. India Dialyzer Market  By End User, From 2021 to 2026 ( USD Billion )

  12. Australia Dialyzer Market  By Type, From 2021 to 2026 ( USD Billion )

  13. Australia Dialyzer Market  By End User, From 2021 to 2026 ( USD Billion )

  14. South Korea Dialyzer Market  By Type, From 2021 to 2026 ( USD Billion )

  15. South Korea Dialyzer Market  By End User, From 2021 to 2026 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports


$ 1234 3335

Click for Request Sample